Real-time enrollment status for this cardiac amyloidosis clinical trial
Current Status
Completed
Checked: June 1, 2026 at 9:52 PM UTC
| NCT Number | NCT06788535 |
| Recruiting Status | Completed |
| Condition | Cardiac Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Sharmila Dorbala |
| Last Updated on CT.gov | April 30, 2026 (Apr 30, 2026) |
As of June 1, 2026: Clinical trial NCT06788535 is currently completed participants. This clinical trial study for cardiac amyloidosis is not currently accepting new participants at 22 locations across the United States. The study is sponsored by Sharmila Dorbala. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06788535 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06788535 was last updated Apr 30, 2026 (April 30, 2026). HelloStudys verifies this status automatically.